Publications & Works

Publication Network
Articles 166
All (166)
SCI-E, SSCI, AHCI (79)
SCI-E, SSCI, AHCI, ESCI (94)
ESCI (15)
Scopus (94)
TRDizin (42)
Other Publications (38)

1. Real-World Outcomes of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

Odabasi Giden A., Özatlı D., ERKURT M. A., Karakus A., SİNCAN G., Hindilerden F., et al.
Hemato , vol.7, no.2, 2026 (ESCI, Scopus)

2. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety

Bakirtas M., Hindilerden I. Y., Ulu B. U., Ekinci O., Dogu M. H., Aydogdu I., et al.
Indian Journal of Hematology and Blood Transfusion , vol.42, no.3, pp.781-791, 2026 (SCI-Expanded, Scopus)

3. CD34+ cell dose as a determinant of engraftment kinetics after autologous stem cell transplantation in lymphoma

SARICI A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.
Journal of Current Hematology & Oncology Research , vol.4, 2026 (TRDizin)

4. The Effect of Nutritional Support on Malnutrition and Muscle Loss in Hematological Cancer Patients: A Retrospective Single-center Study

SARICI A., ERKURT M. A., KAYA E., KUKU İ., BERBER İ., Arslan S., et al.
Acta Haematologica Oncologica Turcica , 2026 (TRDizin)

5. Effect of Interleukin 6 Levels on Allogeneic Stem Cell Transplantation

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
Journal of Applied Hematology , vol.17, pp.161-165, 2026 (Scopus)

6. Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey

Bakırtaş M., BERBER İ., Hindilerden İ. Y., Dal M. S., İzmir Güner Ş., Uysal A., et al.
Journal of Clinical Medicine , vol.15, no.5, 2026 (SCI-Expanded, Scopus)

7. The Impact of Ferritin Levels on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: Real-Life Data

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
Selçuk Tıp Dergisi , vol.42, no.2, pp.168-174, 2026 (TRDizin)

8. A novel preemptive approach to plerixafor use in mobilization failure

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
MARMARA MEDICAL JOURNAL , vol.39, no.1, pp.24-31, 2026 (ESCI, Scopus, TRDizin)

9. Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study

Seçilmiş S., Kabukçu Hacıoğlu S., Hindilerden F., Turgut B., Özatlı D., Akgün Çağlıyan G., et al.
Journal of Clinical Medicine , vol.15, no.2, 2026 (SCI-Expanded, Scopus) Creative Commons License

10. A RARE DIAGNOSIS IN ADULTS: HEREDITARY THROMBOTIC THROMBOCYTOPENIC PURPURA

ARSLAN S., BERBER İ., KUKU İ., KAYA E., ERKURT M. A., SARICI A., et al.
Hematology, Transfusion and Cell Therapy , vol.47, pp.9-1, 2025 (ESCI, Scopus)

11. The comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma

Karakus A., Hatipoglu U., Katircilar Y., ERKURT M. A., Yilmaz S., Cagliyan G. A., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

12. The role of heparin in autologous stem cell mobilization in patients with multiple myeloma

SARICI A., ERKURT M. A., Yilmaz S., Demircioglu S., BERBER İ., Basturk A., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

13. Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference on transplant outcomes?

ERKURT M. A., Yilmaz S., NAMDAROĞLU S., Demircioglu S., SARICI A., Cirik S., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

14. Does body mass index affect stem cell yield in healthy donors?

Yilmaz S., Okumus N., Seyhan M., Sahin R., Korkmaz G., ERKURT M. A., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

15. Is there a relationship between stem cell yield obtained from healthy donors and healthy donors’ blood type?

Katircilar Y., Sahin A., Aydin M. S., Erer K., ERKURT M. A., NAMDAROĞLU S., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

16. The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes

Aslan Candir B., Okumus N., Hindilerden I. Y., ERKURT M. A., NAMDAROĞLU S., Merter M., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

17. The impact of second allogeneic hematopoietic stem cell transplantation as salvage therapy for hematologic diseases after a first allogeneic transplantation

BATGİ H., Zorlu T., ERKURT M. A., UZAY A., Hindilerden I. Y., Pepeler M. S., et al.
Transfusion and Apheresis Science , vol.64, no.4, 2025 (SCI-Expanded, Scopus)

18. Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias

Karakus A., TOPTAŞ T., Dal M. S., Durdu A., Hatipoglu U., Kayer M. A., et al.
Bone Marrow Transplantation , vol.60, no.6, pp.864-872, 2025 (SCI-Expanded, Scopus)

19. What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Ulas T., NAMDAROĞLU S., Hindilerden I. Y., ERKURT M. A., Erer K., Yigenoglu T. N., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

20. Effectiveness of ibrutinib in the management of chronic GVHD

ERKURT M. A., SARICI A., Sahin A., BERBER İ., Korkmaz G., KUKU İ., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

21. Is there a relationship between vitamin D levels and graft versus host disease?

Yigenoglu T. N., Ulu B. U., NAMDAROĞLU S., ERKURT M. A., Sahin R., Okumus N., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

22. Are mesenchymal stem cells still effective in acute GvHD management?

Ulu B. U., Hindilerden I. Y., Yigenoglu T. N., Tiryaki T. O., ERKURT M. A., Korkmaz G., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

23. Efficacy of Ruxolitinib in the management of chronic GVHD

Giden A. O., ERKURT M. A., Hindilerden I. Y., Hidayet E., BERBER İ., Tiryaki T. O., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

24. What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?

Yigenoglu T. N., ERKURT M. A., Dagdas S., Ulu B. U., KUKU İ., Durdu A., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

25. The role of ruxolitinib in the management of acute GVHD

NAMDAROĞLU S., Hidayet E., Aydin M. S., ERKURT M. A., BERBER İ., Cinar O. E., et al.
Transfusion and Apheresis Science , vol.64, no.1, 2025 (SCI-Expanded, Scopus)

26. Etiologic evaluation of male patients diagnosed with anemia in the first consultation of the hematology department

UZUN A., KUKU İ., KAYA E., ERKURT M. A.
Journal of Current Hematology & Oncology Research , vol.3, 2025 (TRDizin)

27. Safety Profile of Roxadustat in Anemic Patients: A Meta-Analysis of 21 RCTs

TANRIVERDİ L. H., SARICI A., ERKURT M. A., BERKTAŞ H. B.
Medeniyet medical journal , vol.40, pp.250-261, 2025 (ESCI, Scopus, TRDizin)

28. Effects of extracorporeal photopheresis on survival in chronic graft versus host disease

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.
MARMARA MEDICAL JOURNAL , vol.37, 2024 (ESCI, Scopus, TRDizin)

29. Relationship between reticular fibrosis with platelet surface markers (CD41A, CD42A, CD42B, CD61) and prognostic markers (WBC, PLT) in acute promyelocytic leukemia

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
ACTA HAEMATOLOGICA POLONICA , vol.55, 2024 (Scopus)

30. The role of therapeutic plasma exchange in the treatment of patients with septic shock- single center experience

Çelik S., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.
Journal of Current Hematology & Oncology Research , vol.2, 2024 (TRDizin)

31. Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?

KAYA A., BERBER İ., KAYA E., ERKURT M. A., BİÇİM S., ARSLAN S., et al.
IRAQI JOURNAL OF HEMATOLOGY , vol.13, 2024 (ESCI, Scopus)

32. Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center

ERYILDIZ S., KUKU İ., KAYA E., ERKURT M. A., BERBER İ.
Journal of Current Hematology & Oncology Research , vol.2, 2024 (TRDizin)

33. Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin’s lymphoma patients

BİÇİM S., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KAYA A., et al.
IRAQI JOURNAL OF HEMATOLOGY , vol.13, 2024 (ESCI, Scopus) Creative Commons License

34. How are the Results of Allogeneic Stem Cell Transplantation in Elderly Patients? A Single-center Experience

Uysal A., ERKURT M. A., KUKU I., Kaya E., BERBER I., SARICI A., et al.
ACTA ONCOLOGICA TURCICA , vol.56, no.2, pp.106-113, 2023 (TRDizin) Creative Commons License

35. A Real-Life Turkish Experience of Ruxolitinib in Polycythemia Vera

SERİN İ., DOĞU M., EKINCI O., ÇAĞLIYAN G. A., BAŞTÜRK A., ARAS M. R., et al.
İstanbul Medical Journal , vol.24, no.2, pp.120-125, 2023 (TRDizin)

36. The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience

Sarıcı A., Erkurt M. A., Kuku İ., Kaya E., Berber İ., Biçim S., et al.
İstanbul Medical Journal , vol.24, no.2, pp.216-220, 2023 (TRDizin)

37. The effect of CD 34+ stem cell dose on both short-term and long-term outcomes of autologous stem cell transplantation in multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
Annals of Medical Research , vol.30, no.3, pp.331-336, 2023 (TRDizin)

38. Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Thalassemia: A Single-Center Experience and Literature Review

UYSAL A., ERKURT M. A., SARICI A., KUKU İ., BİÇİM S., HİDAYET E., et al.
Fırat Tıp Dergisi , vol.28, no.1, pp.46-50, 2023 (TRDizin)

39. A case of malignant melanoma presented with lombar vertebra fracture

SARICI A., KUKU İ., BERBER İ., ERKURT M. A., ER ULUBABA H., BİÇİM S., et al.
Journal of Current Hematology & Oncology Research , vol.1, 2023 (TRDizin) Creative Commons License

40. The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
MARMARA MEDICAL JOURNAL , vol.36, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

41. The frequency of HLA A, B, C, DP, DQ, DR allele in patients of Turkish and Syrian nationals with allogeneic stem cell transplantation

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., BİÇİM S., et al.
IRAQI JOURNAL OF HEMATOLOGY , vol.11, no.2, pp.110-117, 2022 (Peer-Reviewed Journal)

42. Identification of lymphocyte subgroups with flow cytometry in COVID-19 patients

BERBER İ., KIRICI BERBER N., SARICI A., GÖZÜKARA BAĞ H. G., BİÇİM S., TURGUT B., et al.
JOURNAL OF HEALTH SCIENCES AND MEDICINE , vol.5, no.4, pp.1183-1189, 2022 (TRDizin)

43. Effects Of Ethnicity On Allogenic Stem Cell Mobilization

KAYA A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
International Journal of Clinical Images and Medical Reviews , vol.2, no.2, pp.1-4, 2022 (Peer-Reviewed Journal)

44. The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL

Akpinar S., Dogu M. H., ÇELİK S., Ekinci O., Hindilerden I. Y., Dal M. S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.22, no.3, pp.169-173, 2022 (SCI-Expanded, Scopus)

45. Convalescent plasma therapy in COVID-19

UYSAL A., ERKURT M. A., KUKU İ., SARICI A., BİÇİM S., KAYA E., et al.
Medicine Science , vol.11, no.2, pp.920-923, 2022 (TRDizin)

46. Calreticulin Mutations in Philadelphia Chromosome Negative Myeloproliferative Neoplasms

Gulbay G., Bag H. G. G., yesilada e., ERKURT M. A.
Uluslararası Hematoloji-Onkoloji Dergisi , vol.32, no.2, pp.75-80, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

47. The effect of comorbidity on survival and collected CD34+cell counts in autologous hematopoietic stem cell transplant patients

SARICI A., ERKURT M. A., KUKU İ., Bahcecioglu O. F., Bicim S., KAYA E., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.61, no.1, 2022 (SCI-Expanded, Scopus)

48. Psychological well-being in patients undergoing stem cell transplantation

Bayir B., AYLAZ R., ERKURT M. A., Bostanci S.
ACTA SCIENTIARUM-HEALTH SCIENCES , vol.44, pp.1-9, 2022 (ESCI, Scopus) Sustainable Development

49. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers

Basci S., Ata N., Altuntas F., Yigenoglu T. N., Dal M. S., Korkmaz S., et al.
INTERNAL AND EMERGENCY MEDICINE , vol.17, no.1, pp.135-139, 2022 (SCI-Expanded, Scopus) Sustainable Development

50. The effect of cryopreserved and noncryopreserved stem cells on the outcome of autologous stem-cell transplantation in multiple myeloma patients: A single-center experience

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
EGYPTIAN JOURNAL OF HAEMATOLOGY , vol.47, 2022 (Peer-Reviewed Journal)

51. Non-infectious Complications in Patients with Allogeneic Hematopoietic Stem Cell Transplantation- Single Center Experience from Eastern Anatolia

KARAMAN S., SARICI A., ERKURT M. A., BİÇİM S., HİDAYET E., KAYA A., et al.
ACTA ONCOLOGICA TURCICA , vol.55, 2022 (TRDizin)

52. Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia

HİDAYET E., ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., et al.
Medicine Science , vol.11, 2022 (TRDizin)

53. Predictive Significance of Mean Platelet Volume and Platelet Distribution Width Level in Immune Thrombocytopenia Patients Treated With Steroids

KAYA A., KUKU İ., ERKURT M. A., KAYA E., BERBER İ., SARICI A., et al.
International Journal of Research and Reports in Hematology , vol.5, no.1, pp.27-33, 2022 (Peer-Reviewed Journal)

54. The effect of vitamin d and parathyroid hormone level on the number of cd 34 stem cells after mobilization regime in patients with multiple myelom and non hodgkin lymphoma

KAYA A., KAYA E., ERKURT M. A., KUKU İ.
International Journal of Clinical Images and Medical Reviews , vol.1, no.1, pp.1-3, 2022 (Peer-Reviewed Journal) Creative Commons License

55. The Prophylactic Treatment of COVID-19 in a Renal Failure and Hodgkin Lymphoma Patient with Convalescent Plasma

BİÇİM S., BERBER İ., ERKURT M. A., KUKU İ., KAYA E., BİLGİÇ Y., et al.
International Journal of Research and Reports in Hematology , vol.5, no.2, pp.1-5, 2022 (Peer-Reviewed Journal)

56. Life saving effect of early use of convalescent plasma in Covid-19 treatment

SARICI A., ERKURT M. A., KUKU İ., BİÇİM S., BERBER İ., KAYA E., et al.
Annals of Medical Research , vol.28, no.12, pp.2242-2247, 2021 (TRDizin)

57. Pas III Added Donor Platelet Suspensions on Platelet Count Ph and Allergic Transfusion Reactions

Özgül M., KUKU İ., ERKURT M. A., SARICI A., BİÇİM S., BERBER İ., et al.
International Journal of Research and Reports in Hematology , vol.4, no.2, 2021 (Peer-Reviewed Journal)

58. Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience

Sarıcı A., Erkurt M. A., Bahçecioğlu Ö. F., Tanriverdi L. H., Berber İ., Kaya E., et al.
Annals of Medical Research , vol.28, no.11, pp.2065-2070, 2021 (TRDizin)

59. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura

Basturk A., Sayin S., ERKURT M. A., SARICI A., Ekinci O., Kum A., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

60. Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: A multicenter experience

Batgi H., Dal M. S., ERKURT M. A., KUKU İ., Kurtoglu E., Hindilerden I. Y., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

61. Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study

SARICI A., ERKURT M. A., KUKU İ., Gok S., Bahcecioglu O. F., Bicim S., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

62. Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study

Dal Sinan M., Batgi H., ERKURT M. A., Hindilerden I. Y., KUKU İ., Kurtoglu E., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

63. An innovation in stem cell harvesting: Heparin use

GÜL H. G., ERKURT M. A., SARICI A., KUKU İ., KAYA E., BERBER İ., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

64. Therapeutic plasma exchange for envenomation: Is it reasonable?

BERBER İ., Korkmaz S., SARICI A., ERKURT M. A., KUKU İ., KAYA E., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

65. The effect of therapeutic plasma exchange on management of HELLP Syndrome: The report of 47 patients

ERKURT M. A., SARICI A., KUKU İ., BERBER İ., KAYA E., Bicim S., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

66. Apheresis in patients with sepsis: A multicenter retrospective study

Aydin K., Korkmaz S., ERKURT M. A., SARICI A., Ekinci O., Baysal N. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus)

67. Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis

BERBER İ., Cagin Y. F., ERDOĞAN M. A., Ataman E., GÖZÜKARA BAĞ H. G., ERKURT M. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.5, 2021 (SCI-Expanded, Scopus) Sustainable Development

68. Filgrastim alone versus cyclophosphamide and filgrastim for mobilization in multiple myeloma patients

SARICI A., ERKURT M. A., Bahcecioglu O. F., Gok S., KUKU İ., Bicim S., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.4, 2021 (SCI-Expanded, Scopus)

69. Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma-Single center experience

SARICI A., ERKURT M. A., Bahcecioglu O. F., Bicim S., BERBER İ., Gok S., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.60, no.4, 2021 (SCI-Expanded, Scopus)

70. Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience

Goren Sahin D., Akay O. M., KEKLİK M., Okan V., KARAKUŞ A., Demir C., et al.
ANNALS OF HEMATOLOGY , vol.100, no.7, pp.1667-1675, 2021 (SCI-Expanded, Scopus)

71. FLAMSA vs BU-FLU in patients undergoing allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome

SARICI A., ERKURT M. A., KUKU İ., Gök S., Bahçecioğlu Ö. F., BİÇİM S., et al.
Medical Science and Discovery , vol.8, no.6, pp.356-360, 2021 (Peer-Reviewed Journal)

72. Experience of ibrutinib in a patient with recurrent mantle cell lymphoma with orbital involvement

SARICI A., KUKU İ., KAYA E., ERKURT M. A., BERBER İ., BİÇİM S., et al.
Medicine Science , vol.10, no.4, pp.1542-1545, 2021 (TRDizin)

73. Comparison of efficacy and toxicity of treosulfan-fludarabine and busulfan-cyclophosphamide conditioning regimens in patients undergoing allogeneic stem cell transplantation

SARICI A., ERKURT M. A., KUKU İ., BAHÇECİOĞLU Ö. F., GÖK S., BİÇİM S., et al.
Medicine Science , vol.10, no.4, pp.1133-1137, 2021 (TRDizin)

74. COVID-19 in hematopoietic cell transplant recipients

Altuntas F., Ata N., Yigenoglu T. N., Basci S., Dal M. S., Korkmaz S., et al.
BONE MARROW TRANSPLANTATION , vol.56, no.4, pp.952-955, 2021 (SCI-Expanded, Scopus) Sustainable Development

75. BK virus incidence, risk factors and its effect on mortality in hematopoietic stem cell transplant patients-single center experience

DEVİREN M. V., SARICI A., ERKURT M. A., BAHÇECİOĞLU Ö. F., BİÇİM S., BERBER İ., et al.
Medicine Science , vol.10, no.3, pp.856-859, 2021 (TRDizin)

76. The outcome of COVID-19 in patients with hematological malignancy

Yigenoglu T. N., Ata N., Altuntas F., Basci S., Dal M. S., Korkmaz S., et al.
JOURNAL OF MEDICAL VIROLOGY , vol.93, no.2, pp.1099-1104, 2021 (SCI-Expanded, Scopus) Sustainable Development

77. COVID-19 clinical course and blood groups: Turkish population-based study

DAL M. S., Ata N., Altuntas F., Basci S., Yigenoglu T. N., Korkmaz S., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.4, pp.1659-1664, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

78. Comparison of the renal response of bortezomib-based induction and conventional regimen in multiple myeloma patients with renal failure

SARICI A., KAYA E., ERKURT M. A., BERBER İ., TANRİVERDİ L. H., bahçecioğlu ö. f., et al.
Annals of Medical Research , vol.28, no.10, pp.1824-1829, 2021 (TRDizin)

79. Successful treatment with convalescent plasma in Covid-19 disease in relaps/refractory multiple myeloma

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., et al.
Annals of Medical Research , vol.28, no.12, pp.2239-2241, 2021 (Peer-Reviewed Journal) Sustainable Development

80. Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia

ERKURT M. A., SARICI A., BERBER İ., KUKU İ., KAYA E., Ozgul M.
TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.5, 2020 (SCI-Expanded, Scopus) Sustainable Development

81. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

Basci S., Ata N., Altuntas F., Yigenoglu T. N., Dal M. S., Korkmaz S., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.7, pp.1676-1682, 2020 (SCI-Expanded, Scopus) Sustainable Development

82. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG)

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.4, 2020 (SCI-Expanded, Scopus) Sustainable Development

83. Convalescent plasma therapy in patients withCOVID-19

Yigenoglu T. N., HACIBEKİROĞLU T., BERBER İ., Dal M. S., BAŞTÜRK A., Namdaroglu S., et al.
JOURNAL OF CLINICAL APHERESIS , vol.35, no.4, pp.367-373, 2020 (SCI-Expanded, Scopus) Sustainable Development

84. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption

Yigenoglu T. N., Ulas T., Dal M. S., Korkmaz S., ERKURT M. A., Altuntas F.
TRANSFUSION AND APHERESIS SCIENCE , vol.59, no.4, 2020 (SCI-Expanded, Scopus) Sustainable Development

85. Türkiye’xxnin doğusunda non-Hodgkin lenfoma hastalarının klinik ve patolojik özellikleri

DOGAN A., YILDIRIM D. N., ERKURT M. A., EKİNCİ Ö., KUKU İ., KAYA E.
CUKUROVA MEDICAL JOURNAL , vol.45, no.2, pp.533-540, 2020 (ESCI, TRDizin)

86. The Evaluation of Common Chromosomal Rearrangements and Their Frequencies in Adult Acute Myeloid Leukemia Cases in Malatya Province of Turkey

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G.
Eastern Journal Of Medicine , vol.25, no.3, pp.350-355, 2020 (Scopus, TRDizin)

87. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study

Okay M., Aslan T., Ozdemir E., ÜNER A., Saglam A., Gungor E., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.37, no.2, pp.84-90, 2020 (SCI-Expanded, Scopus, TRDizin)

88. Clinical and pathological characteristics of patients with non-Hodgkin lymphoma cases in Eastern Turkey

Dogan A., Dogan N. Y., ERKURT M. A., Ekinci O., KUKU İ., KAYA E.
CUKUROVA MEDICAL JOURNAL , vol.45, no.2, pp.533-540, 2020 (ESCI, TRDizin)

89. Evaluation of the JAK2 V617F gene mutation in myeloproliferative neoplasms cases: a one-center study from Eastern Anatolia

Gülbay G., YEŞİLADA E., ERKURT M. A., BAG H. G., KUKU İ., KAYA E.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, pp.492-498, 2019 (SCI-Expanded, Scopus, TRDizin)

90. Repeat Ultrasonographic Examinations Reveal Accessory Spleen in a Case with Relapse ITP

SARICI A., SLOCUM A., ULUBABA H. E., KANDEMİR M. H., ERKURT M. A., KAYA E., et al.
International Journal of Blood Research and Disorders , vol.6, no.1, pp.1-3, 2019 (Peer-Reviewed Journal)

91. The Turkish experience with therapeutic plasma exchange: A national survey

Korkmaz S., Medeni S. S., DEMİRKAN F., Besisik S. K., Dadin S. A., ÇAĞLIYAN G. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.58, no.3, pp.287-292, 2019 (SCI-Expanded, Scopus)

92. Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study

Ciftciler R., Sevindik O. G., Tekgunduz A. I. E., ERKURT M. A., VURAL F., TURGUT B., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.36, no.3, pp.169-177, 2019 (SCI-Expanded, Scopus, TRDizin)

93. Repeat ultrasonographic examinations reveal accessory spleen in case with relapse ITP

SARICI A., SLOCUM A., ER ULUBABA H., KANDEMİR M. H., ERKURT M. A., KAYA E., et al.
International journal of blood research and disorders , vol.6, no.1, pp.1-3, 2019 (Peer-Reviewed Journal)

94. Stem cell mobilization kinetics in elderly patients with multiple myeloma

Dogu M. H., Batgi H., ERKURT M. A., Hacioglu S., Tekgunduz E., KAYA E., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.57, no.2, pp.204-207, 2018 (SCI-Expanded, Scopus)

95. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., Kaya A. H., KAYNAR L., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.57, no.1, pp.27-30, 2018 (SCI-Expanded, Scopus)

96. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA)

Tekgunduz E., Arat M., GÖKER H., Ozdogu H., KAYNAR L., Cagirgan S., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.56, no.6, pp.845-849, 2017 (SCI-Expanded, Scopus)

97. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma

Dogu M. H., Cagirgan S., Ocakci S., Kaya A. H., Ilkkilic K., Sanli N. M., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.56, no.6, pp.814-818, 2017 (SCI-Expanded, Scopus)

98. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)

Tekgunduz E., DEMİRKAN F., VURAL F., GÖKER H., Ozdogu H., KİKİ İ., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.56, no.6, pp.804-808, 2017 (SCI-Expanded, Scopus)

99. Could platelet indices be prognostic biomarkers for mild or severe acute pancreatitis?

BİLGİÇ Y., AKBULUT A. S., Kutlu O., ÇOLAK C., Yilmaz C., SEÇKİN Y., et al.
International Journal of Clinical and Experimental Medicine , vol.9, no.7, pp.13918-13925, 2016 (SCI-Expanded, Scopus)

100. Assessing Safety of Pneumatic Tube System (PTS) for Patients with Very Low Hematologic Parameters

Koroglu M., ERKURT M. A., KUKU İ., KAYA E., Berber İ., Nizam I., et al.
MEDICAL SCIENCE MONITOR , vol.22, pp.1329-1333, 2016 (SCI-Expanded, Scopus)

101. Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation?

Dogu M. H., KAYA E., Berber İ., SARI İ., Tekgunduz E., ERKURT M. A., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, pp.76-79, 2016 (SCI-Expanded, Scopus)

102. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study

ERKURT M. A., Berber İ., Tekgunduz E., Dogu M. H., Korkmaz S., Demir C., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, pp.80-84, 2016 (SCI-Expanded, Scopus)

103. DHAP plus filgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory lymphoma: A single center experience

BERBER İ., ERKURT M. A., KUKU İ., Maya E., Bag H. G., NIZAM I., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.54, no.1, pp.48-52, 2016 (SCI-Expanded, Scopus)

104. Leukapheresis Treatment in Elderly Acute Leukemia Patients with Hyperleukocytosis: A Single Center Experience

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., Bag H. G., NIZAM I., et al.
JOURNAL OF CLINICAL APHERESIS , vol.31, no.1, pp.53-58, 2016 (SCI-Expanded, Scopus)

105. The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study

TOMBAK A., Ucar M. A., AKDENİZ A., TİFTİK E. N., ŞAHİN F., AKAY O. M., et al.
TURKISH JOURNAL OF HEMATOLOGY , vol.33, no.4, pp.273-280, 2016 (SCI-Expanded, Scopus, TRDizin)

106. Could platelet indices be prognostic biomarkers for mild or severe acute pancreatitis?

BİLGİÇ Y., AKBULUT A. S., KUTLU O., ÇOLAK C., YILMAZ C., SEÇKİN Y., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.9, no.7, pp.13918-13925, 2016 (SCI-Expanded)

107. Could platelet indices be prognostic biomarkers for mild or severe acute pancreatitis?

Bilgic Y., Akbulut S., Kutlu O., Colak C., Yilmaz C., Seckin Y., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.9, no.7, pp.13918-13925, 2016 (SCI-Expanded, Scopus)

108. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience

BERBER İ., KUKU İ., ERKURT M. A., KAYA E., Bag H. G., NIZAM I., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.53, no.2, pp.185-190, 2015 (SCI-Expanded, Scopus)

109. Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes

Dogu M. H., KEKLİK M., TERZİ H., KORKMAZ S., ERKURT M. A., Cagliyan G. A., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.15, 2015 (SCI-Expanded, Scopus)

110. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange

ERKURT M. A., Berber İ., Berktas H. B., KUKU İ., KAYA E., Koroglu M., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.52, no.2, pp.194-198, 2015 (SCI-Expanded, Scopus)

111. Myocardial Infarction in a Splenectomized Patient with Immune Trombocytopenia

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M.
American Journal of Medical Case Reports , vol.3, no.9, pp.301-303, 2015 (Peer-Reviewed Journal)

112. Diclofenac Related Spontaneous Extensive Ecchymosis and Hematoma despite Normal Coagulation Parameters

BERBER İ., ERKURT M. A., NİZAM İ., KUKU İ., KAYA E., ünlü s., et al.
American Journal of Medical Case Reports , vol.3, no.3, pp.82-84, 2015 (Peer-Reviewed Journal)

113. Carcinoma Causing Thrombotic Thrombocytopenic Purpura and Myelonecrosis A Very Rare Event

NİZAM İ., ERKURT M. A., BERBER İ., KÖROĞLU M., KAYA E., KUKU İ., et al.
American Journal of Medical Case Reports , vol.3, no.11, pp.372-373, 2015 (Peer-Reviewed Journal)

114. Can BuCyE conditioning regimen be an alternative treatment to BEAM at autologous transplantation in malignant lymphoma patients?: a single center experience

BERBER İ., ERKURT M. A., NIZAM I., KOROGLU M., KAYA E., KUKU İ., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.8, no.9, pp.16308-16314, 2015 (SCI-Expanded)

115. CLINICAL CHARACTERISTICS, POST-TREATMENT ASSESSMENT AND PROGNOSTIC FACTORS AFFECTING PATIENT SURVIVAL OF PATIENTS AT 65 YEARS OF AGE OR OLDER WITH HODGKIN LYMPHOMA: A RETROSPECTIVE MULTICENTER STUDY FROM TURKEY

Berber İ., ERKURT M. A., KEKLİK M., Dogu M. H., TERZİ H., Pala C., et al.
ACTA MEDICA MEDITERRANEA , vol.31, no.6, pp.1195-1202, 2015 (SCI-Expanded, Scopus)

116. Thrombotic thrombocytopenic purpura presenting with pathologic fracture: a case report

Berber İ., ERKURT M. A., KUKU İ., KAYA E., Unlu S., ERTEM K., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.51, no.1, pp.73-76, 2014 (SCI-Expanded, Scopus)

117. As a Rare Disease Bernard Soulier Syndrome in Differential Diagnosis of Immune Thrombocytopenic Purpura A Case Report

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.
American Journal of Medical Case Reports , vol.2, no.5, pp.102-106, 2014 (Peer-Reviewed Journal)

118. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation

BERBER İ., ERKURT M. A., KUKU İ., KAYA E.
American Journal of Medical Sciences And Medicine , 2014 (Peer-Reviewed Journal)

119. Atypical Presentation of Plasmacytoma

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.
American Journal of Medical Case Reports , vol.2, no.4, pp.82-83, 2014 (Peer-Reviewed Journal)

120. Acute Myeloid Leukemia Significance of the Skin Test

BERBER İ., ERKURT M. A., YARARBAŞ K., KÖROĞLU M., NİZAM İ., BERKTAŞ H. B., et al.
American Journal of Medical Case Reports , vol.2, no.3, pp.55-56, 2014 (Peer-Reviewed Journal)

121. Etiologic Factors of Nonalcoholic Hepatosteathosis in Malatya

GÜNDÜZ E., BENTLİ R., ULUTAŞ Ö., BERBER İ., ERKURT M. A.
Journal of Turgut Ozal MEdicine Center , vol.21, no.2, pp.130-134, 2014 (Peer-Reviewed Journal)

122. Akut myeloid lösemi hastalarında febril nötropenik atakların değerlendirilmesi

CÖMERT M., AYDOĞDU İ., YETKİN F., KAYA E., ERKURT M. A., KUKU İ.
Ege Tıp Dergisi , vol.53, no.1, pp.33-39, 2014 (TRDizin)

123. Aggressive Progression of Mantle Cell Lymphoma ACase Report

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M.
American Journal of Medical Case Reports , vol.2, no.1, pp.30-31, 2014 (Peer-Reviewed Journal)

124. Decitabine Induced Localized Maculopapular Eruption

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., NİZAM İ., KAYA E., et al.
British Journal of Medicine and Medical Research , vol.4, no.4, pp.1002-1007, 2014 (Peer-Reviewed Journal)

125. BK Virus in Allogeneic and Autologous Bone Marrow Transplantation Review Article

BERBER İ., ERKURT M. A., YETKİN F., KUKU İ., KAYA E., bodakcı e., et al.
American Journal of Medical Sciences and Medicine , vol.2, no.5, pp.85-88, 2014 (Peer-Reviewed Journal)

126. A Rare Disease in the Differential Diagnosis of Acute Pancreatitis: Acute Brucellosis

Berber İ., ERKURT M. A., YETKİN F., Unlu S., Yilmaz S., BENTLİ R., et al.
INTERNAL MEDICINE , vol.53, no.20, pp.2401-2404, 2014 (SCI-Expanded, Scopus)

127. An Unexpected Complication of Bone Marrow Aspiration and Trephine Biopsy: Arteriovenous Fistula

Berber İ., ERKURT M. A., KUKU İ., KAYA E., KUTLU R., Koroglu M., et al.
MEDICAL PRINCIPLES AND PRACTICE , vol.23, no.4, pp.380-383, 2014 (SCI-Expanded, Scopus)

128. Donor Selection in Allogeneic Stem Cell Transplantation

ERKURT M. A., BERBER İ., KUKU İ., KAYA E., NİZAM İ.
American Journal of Clinical Medicine Research , vol.2, no.1, pp.32-35, 2014 (Peer-Reviewed Journal)

129. Haploidentical Transplantation Experience in Turgut Ozal MedicalCenter Case Report and a Review of Literature

BERBER İ., ERKURT M. A., KAYA E., KÖROĞLU M., NİZAM İ., BENTLİ R., et al.
Journal of Turgut Ozal Medicine , vol.21, no.1, pp.55-58, 2014 (Peer-Reviewed Journal)

130. Etiologic Evaluation of 1012 Patients Admitted with Thrombocytopenia

ERKURT M. A., BERBER İ., NİZAM İ., KAYA E., KÖROĞLU M., KUKU İ., et al.
British Journal of Medicine and Medical Research , vol.4, no.1, pp.104-113, 2014 (Peer-Reviewed Journal)

131. Evaluation of ferric and ferrous iron therapies in women with iron deficiency anaemia.

BERBER I., DIRI H., ERKURT M. A., AYDOGDU I., Kaya E., KUKU I.
Advances in hematology , vol.2014, pp.297057, 2014 (Scopus) Sustainable Development

132. Hermansky-Pudlak Syndrome: A Case Report

BERBER İ., ERKURT M. A., KUKU I., Kaya E., KOROGLU M., NIZAM I., et al.
CASE REPORTS IN HEMATOLOGY , vol.2014, 2014 (ESCI)

133. Roles of CD5 CD19 CD41a CD55 and CD59 in Chronic Immune Thrombocytopenic Purpura ITP

kaya f., BERBER İ., ERKURT M. A., AYDOĞDU İ., REİSLİ İ.
British Journal of Medicine and Medical Research , vol.4, no.2, 2013 (Peer-Reviewed Journal)

134. Primarily unknown origin adenocarcinoma metastasis in bone marrow presenting with thrombotic thrombocytopenic purpura: A case report

Koroglu M., ERKURT M. A., Berber İ., KUKU İ., KAYA E., Ozkahraman A., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.49, no.2, pp.341-344, 2013 (SCI-Expanded, Scopus)

135. Clinicopathological Characteristics of Pernicious Anemia A Study of 300 Patients in Turkey

BENTLİ R., BERBER İ., ERKURT M. A., AYDOĞDU İ., GÜNDÜZ E., NİZAM İ., et al.
British Journal of Medicine and Medical Research , vol.4, no.3, 2013 (Peer-Reviewed Journal)

136. Extranasal NK Cell Lymphoma with Extensive Skin Involvement A Case Report

ERKURT M. A., BERBER İ., KARADAĞ N., BENTLİ R., KAYA E., KÖROĞLU M., et al.
Journal Of Turgut Ozal Medical Center , vol.20, no.3, pp.276-278, 2013 (Peer-Reviewed Journal)

137. Evans Seyndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.
Journal Of Turgut Ozal Medical Center , vol.20, no.3, pp.289-290, 2013 (Peer-Reviewed Journal)

138. Familial Chronic Lymphocytic Leukemia Patients in Eastern Anatolia Region

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.
Journal Of Turgut Ozal Medical Center , vol.20, no.3, pp.287-288, 2013 (Peer-Reviewed Journal)

139. Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia

ERKURT M. A., Kuku L., KAYA E., Ozgen U., Berber İ., Koroglu M., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.48, no.3, pp.335-339, 2013 (SCI-Expanded, Scopus)

140. Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis

KAYA E., KEKLİK M., ŞENCAN M., Yilmaz M., Keskin A., KİKİ İ., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.48, no.3, pp.349-352, 2013 (SCI-Expanded, Scopus) Sustainable Development

141. Evans Syndrome

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.
İnönü Üniversitesi Tıp Fakültesi Dergisi , vol.20, no.3, pp.289-290, 2013 (TRDizin)

142. Double Hit Lymphoma Presenting with Aggressive Progression A CaseReport

KAYA E., ERKURT M. A., BERBER İ., KÖROĞLU M., KUKU İ.
Journal Of Turgut Ozal Medical Center , vol.20, no.1, pp.74-76, 2013 (Peer-Reviewed Journal)

143. A Rare Case of Chronic Myeloid Leukemia At a Patient with Achondroplasia

NİZAM İ., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.
American Journal of Medical Case Reports , 2013 (Peer-Reviewed Journal)

144. Pulmonary Embolism as the Initial Presentation of Testicular Carcinoma

BERBER İ., BENTLİ R., ERKURT M. A., ULUTAŞ Ö., EDİZ C., NİZAM İ., et al.
CASE REPORTS IN ONCOLOGICAL MEDICINE , vol.2013, 2013 (ESCI) Sustainable Development

145. A Rare Disease in Adult Langerhans Cell Histiocytosis

BERBER İ., ERKURT M. A., KUKU İ., KÖROĞLU M., KAYA E., ÜNLÜ S.
World Journal of Oncology , vol.4, no.3, pp.165-168, 2013 (ESCI)

146. Burkitt s lymphoma presenting with rapidly and multi organ involvement A case presentation

BERBER İ., ERKURT M. A., KÖROĞLU M., KUKU İ., KAYA E., BENTLİ R.
Case Reports in Clinical Medicine , vol.2, no.04, pp.242-245, 2013 (Peer-Reviewed Journal)

147. After allogenic bone marrow transplantation agent of hemorrhagic cystitis BK virus

BERBER İ., KÖROĞLU M., ERKURT M. A., OĞUZ F., ALTINTAŞ R., KAYA E., et al.
Case Reports in Clinical Medicine , vol.2, no.5, pp.298-301, 2013 (Peer-Reviewed Journal)

148. Doğu Anadolu Bölgesindeki Ailesel Kronik Lenfositik Lösemili Hastalarımız

BERBER İ., ERKURT M. A., KÖROĞLU M., BENTLİ R., KAYA E., KUKU İ.
İnönü Üniversitesi Tıp Fakültesi Dergisi , vol.20, no.3, pp.287-288, 2013 (TRDizin)

149. Natriuretic Peptides Role in Determining the Chemotherapy Induced Nephrotoxicity and Their Value in Follow Up

ERKURT M. A., AYDOĞDU İ., KUKU İ., KAYA E., CÖMERT M., BAŞARAN Y.
World Journal of Nephrology & Urology , vol.1, no.1, pp.16-22, 2012 (Peer-Reviewed Journal)

150. Thrombocytopenia in Adults Review Article

ERKURT M. A., KAYA E., BERBER İ., KÖROĞLU M., KUKU İ.
Journal of Hematology , vol.1, pp.44-53, 2012 (ESCI)

151. An Uncommon Case of Acute Brucellosis Presenting with Severe Thrombocytopenia

Dal S. E., ERSOY Y., ERKURT M. A., YETKİN F., KUZUCU Ç., Akdogan O.
INTERNAL MEDICINE , vol.51, no.23, pp.3291-3293, 2012 (SCI-Expanded, Scopus)

152. Atypical Presentation of Herpes Zoster Infection Following Fludarabine Treatment for Chronic Lymphocytic Leukemia: A Case Report

DEMİRCİOĞLU S., AYDOĞDU İ., KAYA E., KUKU İ., ERKURT M. A.
İNÖNÜ ÜNİVERSİTESİ TIP FAKÜLTESİ DERGİSİ , vol.18, no.4, pp.281-283, 2011 (TRDizin)

153. Management of Adult Immun thrombocytopenia Review Article

ERKURT M. A., KAYA E., KUKU İ., KÖROĞLU M., AYDOĞDU İ.
İnönü Üniversitesi Tıp Fakültesi Dergisi , vol.18, no.3, pp.203-212, 2011 (TRDizin)

154. The levels of nitric oxide in megaloblastic anemia

ERKURT M. A., Aydogdu I., BAYRAKTAR N., KUKU İ., KAYA E.
TURKISH JOURNAL OF HEMATOLOGY , vol.26, no.4, pp.197-200, 2009 (SCI-Expanded, Scopus, TRDizin)

155. A multicentric, hyaline vascular variant of Castleman's disease associated with B cell lymphoma: a case report.

ERKURT M. A., AYDOGDU I., KUKU I., Kaya E., MIZRAK B., BASARAN Y.
Cases journal , vol.2, pp.8183, 2009 (Peer-Reviewed Journal)

156. Nodular melanoma presenting with rapid progression and widespread metastases: a case report.

ERKURT M. A., AYDOGDU I., KUKU I., Kaya E., BASARAN Y.
Journal of medical case reports , vol.3, pp.50, 2009 (Scopus)

157. Prevalence of Gallstones in Patients with Chronic Myelocytic Leukemia

Ates F., ERKURT M. A., KARINCAOĞLU M., ALADAĞ M., Aydogdu I.
MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.3, pp.175-179, 2009 (SCI-Expanded, Scopus)

158. Clinicopathologic Characteristics and Therapeutic Outcomes of Primary Gastrointestinal Non-Hodgkin's Lymphomas: 10 Years of Experience from a Single Center in Eastern Anatolia

ERKURT M. A., Aydogdu I., KUKU İ., KAYA E., Basaran Y.
MEDICAL PRINCIPLES AND PRACTICE , vol.18, no.5, pp.399-406, 2009 (SCI-Expanded, Scopus)

159. Kanser kemoterapisi ve böbrek

ERKURT M. A., KUKU İ., KAYA E., AYDOĞDU İ.
TURGUT ÖZAL TIP DERGİSİ , vol.16, no.1, pp.63-68, 2009 (Peer-Reviewed Journal) Sustainable Development

160. Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study

KAYNAR L., Altuntas F., Aydogdu I., Turgut B., KOÇYİĞİT İ., Hacioglu S. K., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.38, no.2, pp.109-115, 2008 (SCI-Expanded, Scopus)

161. Effects of cyanocobalamin on immunity in patients with pernicious anemia

ERKURT M. A., AYDOGDU I., Dikilitas M., KUKU İ., KAYA E., BAYRAKTAR N., et al.
MEDICAL PRINCIPLES AND PRACTICE , vol.17, no.2, pp.131-135, 2008 (SCI-Expanded, Scopus)

162. Anticancer drug induced glomerular dysfunction

ERKURT M. A., AYDOĞDU İ., KUKU İ., KAYA E., ÖZHAN O.
World Journal of Medical Sciences , vol.3, no.1, pp.5-9, 2008 (Peer-Reviewed Journal)

163. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from eastern Anatolia

KAYA E., Erkurt M. A., Aydogdu I., Kuku I., Ozhan O., Oner R. I., et al.
MEDICAL PRINCIPLES AND PRACTICE , vol.16, no.2, pp.100-106, 2007 (SCI-Expanded, Scopus) Sustainable Development

164. Bone relapse in a patient with acute lymphoblastic leukaemia.

AYDOGDU I., Erkurt A., Kaya E., KUKU I.
British journal of haematology , vol.129, pp.163, 2005 (SCI-Expanded, Scopus)

165. Malatya ve Çevresi ABO ve Rh Kan Grubu Dağılımı

KUKU İ., KAYA E., ERKURT M. A., DİKİLİTAŞ M., YILDIZ R., ORHAN M., et al.
Turgut Özal Tıp Merkezi Dergisi , vol.11, no.4, pp.213-215, 2004 (Peer-Reviewed Journal) Sustainable Development

166. Hiperlökositozlu lösemi hastalarımızda terapötik ve proflaktik lökoferez Deneyimlerimiz

KUKU İ., KAYA E., ERKURT M. A., UZER E., ÖZGÜL M., DİKİLİTAŞ M., et al.
Turgut Özal Tıp Merkezi Dergisi , vol.11, no.4, pp.243-246, 2004 (Peer-Reviewed Journal)
Papers Presented at Peer-Reviewed Scientific Conferences 103

1. Otolog Nakil Yapılan Yaşlı Multipl Myelom Hastalarında CONUT Skorunun Prognoza Etkisi

AVCIL A., KAYA E., ERKURT M. A., KUKU İ., BERBER İ., SARICI A.
18. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, 16 April 2026, (Full Text)

2. Multipl Miyelom Hastalarında Transplantasyon Öncesi Conut Skorunun Transplantasyon Sonrası Engraftman Kinetiği ve Genel Sağ kalım Üzerindeki Etkisi

ARSLAN S., SARICI A., KAYA E., KUKU İ., ERKURT M. A., BERBER İ.
51. Ulusal Hematoloji Kongresi’, Antalya, Turkey, 28 October - 01 November 2025, pp.249-250, (Summary Text)

3. Hope or Hazard? The Safety Profile of Roxadustat in Patients With Anemia

SARICI A., BERKTAŞ H. B., ERKURT M. A., TANRIVERDİ L. H.
Annual meeting of the Society of Hematologic Oncology (SOHO 2024), 4 - 07 September 2024, vol.25, pp.653, (Summary Text)

4. TCL-367: A Case of T-PLL Refractory to Multiple Treatments

Arslan S., KUKU İ., KAYA E., ERKURT M. A., BERBER İ., BOZDAĞ Z., et al.
Society of Hematologic Oncology Thirteenth Annual Meeting, Houston, United States Of America, 3 - 06 September 2025, vol.25, (Summary Text)

5. REFRAKTER KRONİK İTP’ DE DANAZOL TEDAVİSİ

ARSLAN S., KAYA E., KUKU İ., ERKURT M. A., BERBER İ., KAYA A.
50. Ulusal Hematoloji Kongresi - 2024, 29 October - 02 November 2024, (Summary Text)

6. İntensif Tedavi Verilemeyen Akut Myeloid Lösemi Hastalarında Venetoklaks Tedavisi Sonuçları: Tek Merkez Deneyim

BİÇİM S., KAYA E., KUKU İ., ERKURT M. A., BERBER İ., KAYA A., et al.
48. Ulusal Hematoloji Kongresi, 1 - 05 November 2022, (Full Text)

7. A Case Report of Liver Involvement in Multiple Myeloma

BİÇİM S., BERBER İ., KUKU İ., KAYA E., ERKURT M. A., KAYA A., et al.
WORLD APHERESIS ASSOCIATION THE EUROPEAN SOCIETY FOR HEMAPHERESIS THE TURKISH SOCIETY OF HEMATOLOGICAL RARE DISEASES HYBRID JOINT CONGRESS, 14 - 17 September 2022, (Full Text)

8. İnönü University Turgut Özal Medical Center Red Crescent Pool Platelet Experience

HİDAYET E., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
WORLD APHERESIS ASSOCIATION THE EUROPEAN SOCIETY FOR HEMAPHERESIS THE TURKISH SOCIETY OF HEMATOLOGICAL RARE DISEASES HYBRID JOINT CONGRESS, İstanbul, Turkey, 14 - 17 September 2022, (Full Text)

9. Otolog Kök Hücre Nakli Öncesi Ferritin Düzeyi Nakil Sonuçlarında Etkili Mi? Tek Merkez Deneyimi

UYSAL A., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., SARICI A., et al.
5. Hematolojik Nadir Hastalıklar Kongresi, Cyprus (Kktc), 24 - 27 March 2022, (Summary Text)

10. HA330 Hemoperfüzyon Adsorbsiyon yönteminin sepsiste inflamatuar belirteçler ve end organ hasar düzeyleri üzerine etkileri: Retrospektif tek merkezli çalışma

ERKURT M. A., SARICI A., ÖZER A. B., KUKU İ., KAYA E., BİÇİM S., et al.
5. Hematolojik Nadir Hastalıklar Kongresi, Cyprus (Kktc), 24 - 27 March 2022, (Summary Text)

11. Philadelphia kromozomu negatif miyeloproliferatif neoplazilerinde kalretikülin mutasyonları

GÜLBAY G., GÖZÜKARA BAĞ H. G., YEŞİLADA E., ERKURT M. A.
XVII. Tıbbi Biyoloji ve Genetik Kongresi 28-31 Ekim 2021 Online, 28 October 2021, vol.52, pp.364-365, (Summary Text)

12. MİYELOFİBROZİSE SEKONDER MULTİPLE MİYELOM: NADİR GÖRÜLEN BİR OLGU SUNUMU

BİÇİM S., SARICI A., ŞAHİN A. Ş., BERBER İ., KUKU İ., KAYA E., et al.
4. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, DİJİTAL KONGRE, Turkey, 30 September - 03 October 2021, pp.41-44, (Summary Text)

13. MULTİPL MYELOM HASTASINDA GÖRÜLEN COVİD-19 HASTALIĞI

SARICI A., BİLGİÇ Y., AKBAŞ S., BİÇİM S., BERBER İ., ERKURT M. A., et al.
3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Turkey, 25 - 27 December 2020, pp.148-149, (Summary Text)

14. OTOLOG HEMATOPOETİK KÖK HÜCRE NAKLİ YAPILAN MİKOZİS FUNGOİDES VAKASI

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.
3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Turkey, 25 - 27 December 2020, pp.153, (Summary Text)

15. AKUT LENFOBLASTİK LÖSEMİLİ HASTADA GÖRÜLEN CİLT TUTULUMU

SARICI A., BİÇİM S., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.
3. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, ONLINE KONGRE, Turkey, 25 - 27 December 2020, pp.150, (Summary Text)

16. Hemoglobin S Polimerizasyon İnhibitörü Voxelotor’un Orak Hücre Hastalığındaki Etkililiği ve Güvenliliği: Randomize Kontrollü Çalışmaların Sistematik Derlemesi ve Meta-Analizi

TANRIVERDİ L. H., SARICI A., PARLAKPINAR H., ERKURT M. A.
25. Ulusal Farmakoloji Kongresi, İzmir, Turkey, 04 November 2019, (Summary Text)

17. TANI ANINDA BÖBREK YETMEZLİĞİ OLAN MULTİPL MYELOM HASTALARININ TEDAVİ SONRASI BÖBREK FONKSİYONLARININ DEĞİŞİMİ

SARICI A., KAYA E., ERKURT M. A., TANRIVERDİ L. H., BERBER İ., BAHÇECİOĞLU Ö. F., et al.
45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October - 02 November 2019, pp.219, (Summary Text)

18. GRAFT VERSUS HOST HASTALIĞINDA İBRUTİNİBKULLANIMI: TEK MERKEZ DENEYİMİ

ÖZKAN S. G., KAYA E., ERKURT M. A., SARICI A., BERBER İ., KUKU İ.
45. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 30 October - 02 November 2019, (Full Text)

19. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic transplantation: Retrospective multicenter study of Turkish hematology research and education group (THREG), updated data

SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.254-255, (Summary Text)

20. Meme Kanseri Tedavisi Sonrası Gelişen Akut Myeloid Lösemi Olgusu

SARICI A., Yiğit O. S., BAHÇECİOĞLU Ö. F., GÖK S., ERKURT M. A., KAYA E., et al.
VI.ULUSLARARASI KATILIMLI DENEYSEL HEMATOLOJİ KONGRESİ, Gaziantep, Turkey, 19 - 21 April 2019, pp.1-2, (Summary Text)

21. TEKRARLAYAN SEREBROVASKÜLER OLAY ATAKLARI VE DALAK ENFARKTI İLE GELEN BİR PANMYELOZİS OLGUSU

SARICI A., ŞAHİN F. T., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.69, (Summary Text)

22. AKUT MYELOİD LÖSEMİ TANILI HASTADA SİTARABİN KEMOTERAPİSİ ESNASINDA TROMBOSİTOZ GELİŞİMİ

SLOCUM A., SARICI A., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.49, (Summary Text)

23. HEMATOPOETİK KÖK HÜCRE NAKLİ’NDE DONÖR OLAN VAKADA HODGKİN LENFOMA GELİŞİMİ

SARICI A., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.66, (Summary Text)

24. BETA TALASEMİ MAJOR TANILI HASTADA ALLOGENEİK KÖK HÜCRE NAKLİ SONRASI ENGRAFTMAN GELİŞMEMESİ

SARICI A., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.65, (Summary Text)

25. ERİŞKİNDE NADİR GÖRÜLEN KONGENİTAL DİSERİTROPOİETİK SENDROM- II OLGUSU

SARICI A., ŞAHİN F. T., ERKURT M. A., KAYA E., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.68, (Summary Text)

26. TURGUT ÖZAL TIP MERKEZİ’NDE TAKİP EDİLEN KRONİK MYELOİD LÖSEMİ TANILI HASTALARIN TEDAVİ YANITLARI

SARI M., SARICI A., KAYA E., ERKURT M. A., KUKU İ.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.63, (Summary Text)

27. İDİOPATİK TROMBOSİTOPENİK PURPURA TANILI HASTADA TROMBOSİTOPENİ NEDENİ OLARAK TESPİT EDİLEN AKSESUAR DALAK

SARICI A., KUKU İ., ERKURT M. A., KAYA E.
2. HEMATOLOJİK NADİR HASTALIKLAR KONGRESİ, BAFRA, Cyprus (Kktc), 7 - 09 February 2019, pp.51, (Summary Text)

28. Non-Hodgkin Lenfoma Hastalarının Klinik ve Patolojik Özellikleri: Tek Merkez Deneyimi.

YILDIRIM DOĞAN N., ERKURT M. A., DOĞAN A., EKİNCİ Ö., KUKU İ., KAYA E.
44. Ulusal Hematoloji Kongresi., 31 October - 03 November 2018, (Summary Text)

29. Clinical and pathological characteristics of non-Hodgkin lymphoma patients in eastern Turkey: a single-center study.

YILDIRIM DOĞAN N., ERKURT M. A., DOĞAN A., EKİNCİ Ö., KUKU İ., KAYA E.
IXth International Eurasian Hematology Oncology Congress., İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)

30. Relation of basal vitamin D and parathyroid hormone levels to CD34 cell counts in multiple myeloma and lymphoma patients with stem cell mobilization

KAYA A., KAYA E., ERKURT M. A., KUKU İ.
9th International Eurasian Hematology Oncology Congress, İstanbul, Turkey, 17 - 20 October 2018, vol.73, no.1, pp.34-70, (Full Text)

31. Relation of Basal Vitamin D and Parathyroid Hormone Levels to CD34+ Cell Counts in Multiple Myeloma and Lymphoma Patients with Stem Cell Mobilization

KAYA A., KAYA E., ERKURT M. A., KUKU İ.
IX. International Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Full Text)

32. Thrombocytapheresis decreases systolic blood pressure and increases sympatho-vagal balance

ERKURT M. A., KAYA E., KUKU İ., YILDIZ S.
9th International Eurasian Hematology Oncology Congress, İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Full Text)

33. Akut Myeloid Lösemili Olgularımızda T(15 17) PML-RARA, T(8 21) RUNX1-RUNX1T1, inv 16 CBFB-MYH11A ve t(9 22) BCR-ABL1 Pozitifliğinin Araştırılması

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KAYA E., KUKU İ.
V.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Malatya, Turkey, 27 - 29 April 2018, (Summary Text)

34. Philadelphia Kromozomu Negatif Hastalarda JAK2 V617F Gen Mutasyonunun Değerlendirilmesi

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KAYA E., KUKU İ.
V.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Malatya, Turkey, 27 - 29 April 2018, (Summary Text)

35. Türk Hastalarda Jak2 V617f Gen Mutasyonunun Değerlendirilmesi: Doğu Anadolu’xxdan Tek Merkez Deneyimi

GÜLBAY G., YEŞİLADA E., ERKURT M. A., GÖZÜKARA BAĞ H. G., KUKU İ., KAYA E.
I. Hematolojik Nadir Hastalıklar Kongresi, Girne, Cyprus (Kktc), 8 - 10 February 2018, pp.40, (Summary Text)

36. myokard infarktüsü ile prezente olan izole trombositozlu kronik myeloid lösemi: olgu sunumu

CIRIK S., ÖZKAN M., KAYA E., KUKU İ., ERKURT M. A.
43.Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

37. BORTEZOMİB İLİŞKİLİ İŞİTME KAYBI

ÖZKAN M., ÖZEN İ. N., KUKU İ., KAYA E., ERKURT M. A.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Full Text)

38. MYELOM SEYRİNDE ASİT OLUŞUMU

ÖZKAN M., KUŞCU A., KUKU İ., KAYA E., ERKURT M. A.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Full Text)

39. MİYOKARD İNFARKTÜSÜ İLE PREZENTE OLAN İZOLETROMBOSİTOZLU KRONİK MYELOİD LÖSEMİ:OLGU SUNUMU

CIRIK S., ÖZKAN M., KAYA E., KUKU İ., ERKURT M. A.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Full Text)

40. Mean corpuscular volüme can be early predictor for molecular response in chronic phase chronic myeloid leukemia patients

ÖZKAN M., KAYA E., CIRIK S., KUKU İ., ERKURT M. A.
VIII. International Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 18 - 21 October 2017, vol.61, no.1, pp.52, (Summary Text)

41. Myeloid Sarcoma of the Tongue with Myelodysplastic Syndrome: A Case Report

CIRIK S., ÖZKAN M., KUKU İ., KAYA E., ERKURT M. A.
4th Aegean Hematology Oncology Congress, 21 - 24 September 2017, (Summary Text)

42. Bortezomib Associated Hearing Loss

ÖZKAN M., KAYA E., ERKURT M. A., KUKU İ.
4Th Aegean Hematology Oncology Congress, 21 - 24 September 2017, (Summary Text)

43. A Multicenter Experience of Thrombotic Microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 Study

Tekgunduz E., YILMAZ M., ERKURT M. A., KİKİ İ., KAYA E., KAYNAR L., et al.
58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), California, United States Of America, 3 - 06 December 2016, vol.128, (Summary Text)

44. THE TROUBLE THAT HEMATOLOGISTS DEALING WITH: VARICELLA-ZOSTER AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

ÖZKAN M., OZEN I. N., DOLASIK I., KAYA E., ERKURT M. A., KUKU İ.
21st Congress of the European-Hematology-Association, Copenhagen, Denmark, 9 - 12 June 2016, vol.101, pp.864, (Summary Text)

45. BİLİNÇ BULANIKLIĞIYLA ORTAYA CIKAN SANTRAL SİNİR SİSTEMİNDE İNVAZİV ASPERGİLLUS ENFEKSİYONU

NİZAM İ., ERKURT M. A., KUKU İ., KAYA E., CÖMERT ÖZKAN M., DOLAŞIK İ.
2.EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, Turkey, 18 - 20 March 2016, (Full Text)

46. POSTTRANSPLANT 5q del SAPTANAN AKUT LENFOBLASTİK LÖSEMİ OLGUSU

ÖZKAN M., NİZAM İ., DOLAŞIK İ., KUKU İ., KAYA E., ERKURT M. A.
2. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, Turkey, 18 - 20 March 2016, (Summary Text)

47. BİLİNÇ BULANIKLIĞI İLE ORTAYA ÇIKAN SANTRAL SİNİR SİSTEMİNDE İNVASİF ASPERGİLLÜS ENFEKSİYONU

NİZAM İ., ERKURT M. A., KUKU İ., KAYA E., ÖZKAN M., DOLAŞIK İ., et al.
2.EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, Turkey, 18 - 20 March 2016, (Summary Text)

48. Mapping of blood coagulation via image processing method Kan Pihtdaimasinin Görüntü Işleme Yöntemiyle Haritalandirilmasi

Onar B., Bayindir M., BİLGİLİ H., ERKURT M. A., Yakinci C., YAKINCI M. C.
Medical Technologies National Conference, TIPTEKNO 2015, Bodrum, Turkey, 15 - 18 October 2015, (Full Text)

49. Deri Tutulumu İle Prezente Extranodal NHL Olgu Sunumu

KUM A., ERKURT M. A., NİZAM İ., BERBER İ., KAYA E., KUKU İ., et al.
10.Ulusal Aferez Kongresi, İstanbul, Turkey, 5 - 08 November 2015, (Full Text)

50. Kadın Hastada Hemofili A

ÖZEN NİZAM İ., ERKURT M. A., KAYA E., BERBER İ., DOLAŞIK İ., CÖMERT ÖZKAN M., et al.
10.Ulusal Aferez Kongresi, İstanbul, Turkey, 5 - 08 November 2015, (Full Text)

51. Akut Myeloid Lösemi Tanılı Hastada Nadir Bir Durum Fournier Gangreni

DOLAŞIK İ., ERKURT M. A., NİZAM ÖZEN İ., HİDAYET E., CÖMERT ÖZKAN M., KAYA E., et al.
10.Ulusal Aferez Kongresi, İstanbul, Turkey, 5 - 08 November 2015, (Full Text)

52. YILAN ZEHİRLENMESİNDE ETKİLİ VE GÜVENLİ BİR TEDAVİ YÖNTEMİ PLAZMA DEĞİŞİMİ

NİZAM ÖZEN İ., ERKURT M. A., BERBER İ., KUKU İ., KAYA E., CÖMERT ÖZKAN M., et al.
10.ULUSAL AFEREZ KONGRESİ, İstanbul, Turkey, 5 - 08 November 2015

53. BÖBREK NAKLİ YAPILAN HASTALARDA ATİPİK HÜS DENEYİMİMİZ

KUM A., ÖZEN İ. N., ERKURT M. A., KAYA E., KUKU İ., BERBER İ., et al.
10. AFEREZ KONGRESİ, Turkey, 5 - 08 November 2015

54. Turgut Özal Tıp Merkezi Kemik İliği Nakli Merkezi nin 5 Yıllık Mobilizasyon Deneyimi

ÖZEN İ. N., ERKURT M. A., KAYA E., KUKU İ., BERBER İ., DOLAŞIK İ., et al.
10. ULUSAL AFEREZ KONGRESİ, Turkey, 5 - 08 November 2015, pp.50

55. TROMBOTİK TROMBOSİTOPENİK PURPURA VE MYELONEKROZA NEDEN OLAN KARSİNOM

NİZAM İ., ERKURT M. A., BERBER İ., KÖROĞLU M., KAYA E., KUKU İ., et al.
TÜRK HEMATOLOJİ DERNEĞİ 41. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 21 - 24 October 2015, pp.315

56. İMMÜN TROMBOSİTOPENİDE STEROİDE BAĞIMLI ELTROMBOPAG YANITI

NİZAM İ., KAYA E., BERBER İ., CÖMERT ÖZKAN M., ERKURT M. A., KUKU İ.
Türk Hematoloji Derneği 41. Ulusal Hematoloji Kongresi, Turkey, 21 - 24 October 2015, pp.175

57. ALLOJENİK VE OTOLOG KÖK HÜCRE NAKLİNDE BK VİRÜS TURGUT ÖZAL TIP MERKEZİ TEK MERKEZ DENEYİMİ

ERKURT M. A., BERBER İ., NİZAM İ., SELÇUK E. B., SERAP B., KAYA E., et al.
2.HEMATOLOJİK ONKOLOJİ VE KEMİK İLİĞİ TRANSPLANTASYON SEMPOZYUMU, Turkey, 5 - 08 February 2015

58. The Clinical Characteristics and Therapeutic Outcomes of Elderly Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicenter Study

Tombak A., Tiftik N., Dogu M. H., Sari I., Akay M. O., Karagulle M., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Costa Rica, 6 - 09 December 2014, vol.124, (Summary Text)

59. UYGUN DONÖRLERDE ÜÇLÜ DOZ TROMBOSİT AFEREZİ DOĞU ANADOLU DAN TEK MERKEZ DENEYİMİ

ÖZGÜL M., ÖZEN İ. N., ERKURT M. A., KUKU İ., BERBER İ., DOLAŞIK İ., et al.
10.AFEREZ KONGRESİ, Turkey, 5 - 08 November 2015, (Full Text)

60. Leukapheresis in elderly patients are safe and effective treatment

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., NİZAM İ., GÖZÜKARA BAĞ H. G., et al.
IX. Ulusal Aferez Kongresi, Cyprus (Kktc), 4 - 07 September 2014, pp.177-178, (Summary Text)

61. Bu Cy E Conditioning Regimen Can Be An Alternative Treatment to BEAM at Autologous Transplantation for Lymphoma

ERKURT M. A., BERBER İ., NİZAM İ., KAYA E., KUKU İ.
IX. Ulusal Aferez Kongresi, Turkey, 4 - 07 September 2014

62. Carcinoma Causing Thrombotic Thrombocytopenic Purpura andMyelonecrosis A Very Rare Event

NİZAM İ., ERKURT M. A., BERBER İ., KÖROĞLU M., KAYA E., KUKU İ.
9. ULUSAL AFEREZ KONGRESİ, Turkey, 4 - 07 September 2014

63. UYgun Donörlerde ÜÇlü Doz Trombosit Aferezi Doğu Anadolu dan Tek Merkez Deneyimi

ÖZGÜL M., NİZAM İ., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., et al.
9. ULUSAL AFEREZ KONGRESİ, Turkey, 4 - 07 September 2014

64. FEBRİL NÖTROPENİ ATAKLARINDA ANTİBİYOTİK MODİFİKASYON NEDENLERİ TURGUT ÖZAL TIP MERKEZİ HEMATOLOJİ KLİNİĞİ DENEYİMİ

KÖROĞLU M., KUKU İ., ERKURT M. A., KAYA E., NİZAM İ., BERBER İ., et al.
39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 - 26 October 2013, pp.89-90

65. PRIMARY BREAST LYMPHOMA IN A MALE PATIENT

BERBER İ., ERKURT M. A., yiğit a., KAYA E., KUKU İ., KÖROĞLU M., et al.
IV. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, Antalya, Turkey, 9 - 13 October 2013, vol.3, pp.129

66. MULTIPLE MYELOMA PRESENTING WITH BLEEDING DIATHESIS A CASE REPORT

NİZAM İ., ERKURT M. A., KAYA E., BERBER İ., KÖROĞLU M., BENTLİ R., et al.
4. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 9 - 13 October 2013

67. CHRONIC MYELOİD LEUKEMIA PRESENTING A MAN WİTH A AT CHONDROPLASIA A RARE CASEINTRODUCTlON

NİZAM İ., ERKURT M. A., KAYA E., KÖROĞLU M., BERBER İ., BENTLİ R., et al.
4. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 9 - 13 October 2013

68. ÖLÜMCÜL SEYREDEBİLEN BİR HASTALIK SOĞUK HEMAGLÜTİNİN HASTALIĞI

YAĞAR Y., KÖROĞLU M., ERKURT M. A., KUKU İ., KAYA E., BERBER İ., et al.
8. ULUSAL AFEREZ KONGRESİ, Cyprus (Kktc), 5 - 08 September 2013, pp.164

69. İNÖNÜ ÜNİVERSİTESİ TURGUT ÖZAL TIP MERKEZİ AFEREZ ÜNİTESİNDE TOPLANAN TROMBOSİTLERİN HAZIRLANIŞ ŞEKİLLERİNE GÖRE SAYILARI

KAYA E., ERKURT M. A., BERBER İ., KÖROĞLU M., NİZAM İ., ULU E., et al.
8. ULUSAL AFEREZ KONGRESİ, Cyprus (Kktc), 5 - 08 September 2013

70. TURGUT ÖZAL TIP MERKEZİNDE BÖLÜMLERE GÖRE KAN VE KAN ÜRÜNÜ ÇIKIŞI

KÖROĞLU M., BERKTAŞ H. B., ERKURT M. A., KUKU İ., KAYA E., NİZAM İ., et al.
8. ULUSAL AFEREZ KONGRESİ, Cyprus (Kktc), 5 - 08 September 2013, pp.162-163

71. SUCCESSFUL TREATMENT OF HELLP SYNDROME BY PLASMAPHERESIS

ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KÖROĞLU M., NİZAM İ., et al.
8. ULUSAL AFEREZ KONGRESİ, Cyprus (Kktc), 5 - 08 September 2013

72. AKUT MYELOİD LÖSEMİDE CİLT MUAYENESİ VE ÖNEMİ

BERBER İ., ERKURT M. A., KAYA E., NİZAM İ., KUKU İ., KÖROĞLU M., et al.
8. ULUSAL AFEREZ KONGRESİ, Cyprus (Kktc), 5 - 08 September 2013

73. Metotreksata Bağlı Toksik Epidermal Nekrolizis

YILMAZ S., BERBER İ., ERKURT M. A., KAYA E., KÖROĞLU M., NİZAM İ., et al.
8.ULUSAL AFEREZ KONGRESİ, Turkey, 5 - 08 September 2013

74. Experience Of BK Virus In Allogenic And Otolog Bone Marrow Transplantation

ERKURT M. A., BERBER İ., KAYA E., KÖROĞLU M., NİZAM İ., KUKU İ., et al.
Ulusal Aferez Kongresi, Turkey, 5 - 08 September 2013

75. DEMİR EKSİKLİĞİ ANEMİSİNE BAĞLI REAKTİF TROMBOSİTOZU OLAN HASTALARDA HELİCOBAKTER PYLORİ SIKLIĞININ ARAŞTIRILMASI

KOÇ M. S., KUKU İ., KAYA E., ERKURT M. A., KÖROĞLU M., BERBER İ., et al.
8. ULUSAL AFEREZ KONGRESİ, Cyprus (Kktc), 5 - 08 September 2013, pp.148, (Summary Text)

76. KEMİK İLİĞİ İNCELEMESİ SONRASINDA NADİR BİR KOMPLİKASYON A V FİSTÜL

BERBER İ., ERKURT M. A., BAZNA S., KAYA E., NİZAM İ., KÖROĞLU M., et al.
8. ULUSAL AFEREZ KONGRESİ, Cyprus (Kktc), 5 - 08 September 2013, pp.149-150

77. AKUT MYELOİD LÖSEMİLİ ÜÇ OLGUDA GELİŞEN ÖNEMLİ BİR PROBLEM TROMBOSİT ALLOİMMÜNİZASYONU

KÖROĞLU M., ERKURT M. A., KAYA E., BERBER İ., KUKU İ.
38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, pp.90-91

78. ERİŞKİNDE LANGERHANS HÜCRELİ HİSTİYOSİTOZİS OLGU SUNUMU

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., KÖROĞLU M., ÖZDEMİR Z.
38. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October - 03 November 2012

79. İMMÜN TROMBOSİTOPENİN BİRİNCİ BASAMAK TEDAVİSİNDE DEKSAMETAZON DENEYİMİMİZ

ERKURT M. A., BERBER İ., KAYA E., KUKU İ., KÖROĞLU M., ÖZDEMİR Z.
38. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October - 03 November 2012

80. AKUT MYELOİD LÖSEMİ M3 TİPİ OLGULARIMIZ

KÖROĞLU M., ERKURT M. A., KAYA E., BERBER İ., KUKU İ.
38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, pp.91

81. MULTİPLE MYELOMDA OTOLOG KEMİK İLİĞİ NAKLİ DENEYİMİMİZ

BERBER İ., ERKURT M. A., KAYA E., KUKU İ., KÖROĞLU M.
38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, pp.229-230

82. HEMATOLOJİ KONSÜLTASYONU İSTENEN HASTALARIN BÖLÜMLERE VE İSTEM NEDENLERİNE GÖRE DAĞILIMI

KÖROĞLU M., ERKURT M. A., BERBER İ., KAYA E., KUKU İ.
38. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October - 04 November 2012

83. ALLOJENİK KEMİK İLİĞİ NAKLİ SONRASI HEMORAJİK SİSTİT ETKENİ BK VİRÜS

ERKURT M. A., BERBER İ., KAYA E., OĞUZ F., KUKU İ., KÖROĞLU M.
38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, pp.132-133

84. İMMÜN TROMBOSİTOPENİLİ HASTALARIMIZIN DEMOGRAFİK VERİLERİ VE KLİNİK ÖZELLİKLERİ TEDAVİ SONUÇLARI

BERBER İ., ERKURT M. A., KUKU İ., KAYA E., KÖROĞLU M.
38. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October - 03 November 2012

85. AKUT MYELOİD LÖSEMİ HASTALARINDA HİPERLÖKOSİTOZ

KÖROĞLU M., BERBER İ., ERKURT M. A., KAYA E., KUKU İ.
38. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2012, pp.99

86. HAND FOOT SYNDROME CASE İN İNONİJUNIVERSITY FACULTY OF MEDİCİNEDEPARTMENT OF HEMATOLOGY

KAYA E., KARINCAOĞLU Y., ERKURT M. A., KUKU İ., BERBER İ., KÖROĞLU M., et al.
3. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, 17 - 21 October 2012

87. HAND FOOT SYNDROME CASE IN INONU UNIVERSITY FACULTY OF MEDICINE DEPARTMENT OF HAEMATOLOGY

KAYA E., KARINCAOĞLU Y., ERKURT M. A., KUKU İ., BERBER İ., KÖROĞLU M., et al.
III. INTERNATIONAL EURASIAN HEMATOLOGY CONGRESS, Antalya, Turkey, 17 - 21 October 2012, vol.2, pp.300

88. Therapeutic Plasma Exchange in Patents with Neurologic Diseases Multicenter Retrospective Analysis

KAYA E., MUZAFFER K., ŞENCAN M., YILMAZ M., KESKİN A., KİKİ İ., et al.
14th International Congress of World Apheresis Society and 7th National Congress of Turkish Society of Apheresis., 13 - 15 September 2012, vol.47, pp.7

89. STEM CELL TRANSPLANTATION EXPERIENCE OF TURGUT OZAL MEDICAL CENTER A SINGLE CENTER EXPERIENCE IN EASTERN ANATOLIA

ERKURT M. A., KUKU İ., KAYA E., BERBER İ., KÖROĞLU M.
14th International Congress of the World Apheresis, İstanbul, Turkey, 13 - 15 September 2012, vol.47, pp.27

90. Thrombotic Thrombocytopenic Purpura presented with 43 times applied plasma exchange

ERKURT M. A., KAYA E., KUKU İ., KÖROĞLU M., BERBER İ.
14th INTERNATIONAL CONGRESS OF WORLD APHERESIS ASSOCIATION, Turkey, 13 - 15 September 2012, vol.47, pp.48

91. KEMİK İLİĞİ NAKİL MERKEZİ KÜLTÜR SONUÇLARIMIZ TEK MERKEZ DENEYİMİ

KÖROĞLU M., BERBER İ., KAYA E., ERKURT M. A., KUKU İ.
7. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 8 - 10 March 2012, pp.171, (Summary Text)

92. İNÖNÜ ÜNİVERSİTESİ TIP FAKÜLTESİ TURGUT ÖZAL TIP MERKEZİ KEMİK İLİĞİ NAKİL MERKEZİ ERKEN DÖNEM SONUÇLARI

ERKURT M. A., KAYA E., KUKU İ., ÖZGÜL M., KÖROĞLU M., CÖMERT M.
37. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 19 - 22 October 2011

93. Nüks ve Refrakter NHL Hastalarında DHAP Tedavisi

KUKU İ., KAYA E., ERKURT M. A., ORHAN M., GÖRGEL A., BARAN M., et al.
31. Ulusal Hematoloji Kongresi Bildiri 230, Poster 140., Antalya, Turkey, 23 - 28 September 2004, (Summary Text)

94. Malatya ve Çevresi ABO ve Rh Kan Grubu Dağılımı

KUKU İ., KAYA E., ERKURT M. A., ORHAN M., BARAN M., ESKİN F., et al.
31. Ulusal Hematoloji Kongresi Bildiri 310, Poster 220., Antalya, Turkey, 23 - 28 September 2004, (Summary Text)

95. Akut Miyelositer Lösemi Hastalarımızda CD38 Ekspresyonu

KUKU İ., ERKURT M. A., KAYA E., ORHAN M., BARAN M., GÖRGEL A., et al.
31. Ulusal Hematoloji Kongresi Bildiri 94, Poster 4., Antalya, Turkey, 23 - 28 September 2004, (Summary Text)

96. Kollojen Doku Hastalığı İle Takip Edilen Dört Hastada Görülen Kronik Miyelositer Lösemi

ŞENEL S., KAYA E., Kuku I., ERKURT M. A., ÖNER R. İ., Özhan O., et al.
XXX. Ulusal Hematoloji Kongresi, İstanbul, Turkey, 10 - 14 October 2003, pp.221, (Summary Text)

97. Doğu Anadoluda bulunan merkezimizdeki lenfomalı hastaların tanı sırasındaki klinik özellikleri ve seyirleri

BAYDAR M., KUKU İ., KAYA E., DİKİLİTAŞ M., ATEŞ F., ERKURT M. A., et al.
Türk Hematoloji Derneği 29. Ulusal Kongresi, Antalya, Turkey, 25 - 28 October 2002

98. Lenfoproliferatif hastalıklarda fludarabin kullanımı

KUKU İ., AYDOĞDU İ., KAYA E., ATEŞ F., ERKURT M. A., ŞEREFHANOĞLU S.
29. Ulusal Hematoloji Kongresi, Antalya, Turkey, 25 - 28 October 2002, (Full Text)

99. İdiopatik trombositopenik purpurada oral yüksek doz steroid tedavisi sonuçlarımız

KUKU İ., AYDOĞDU İ., KAYA E., BAYDAR M., DİKİLİTAŞ M., ATEŞ F., et al.
Türk Hematoloji Derneği 29. Ulusal Kongresi, Antalya, Turkey, 25 - 28 October 2002

100. İdiopatik trombositopenik purpura tanısı ile izlenen hastalarımızda splenektomi tedavisinin sonuçları

KUKU İ., KAYA E., ATEŞ F., ERKURT M. A., ULU R., DİKİLİTAŞ M., et al.
Türk Hematoloji Derneği 29. Ulusal Kongresi, Antalya, Turkey, 25 - 28 October 2002

101. TANI ANINDA HİPERLÖKOSİTOZUN EŞLİK ETTİĞİ AKUT MİYELOBLASTİK LÖSEMİLİ HASTALARIMIZIN KLİNİK ÖZELLİKLERİ VE PROGNOZLARI

KAYA E., KUKU İ., AYDOĞDU İ., ULU R., ERKURT M. A., ATEŞ F., et al.
TÜRK HEMATOLOJİ DERNEĞİ 29. ULUSAL KONGRESİ, Turkey, 25 - 28 October 2002, (Full Text)

102. Tanı anında hiperlökositozun eşlik ettiği lösemili hastalarımızın klinik özellikleri ve prognozları

KAYA E., Kuku I., Aydogdu I., ULU R., ERKURT M. A., Ates F., et al.
XXIX. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 October 2002, pp.228, (Summary Text)

103. İdyopatik Trombositopenik Purpurada oral yüksek doz steroid tedavisi sonuçlarımız

Kuku I., Aydogdu I., KAYA E., Baydar M., DİKİLİTAŞ M., Ates F., et al.
XXIX. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 October 2002, pp.135, (Summary Text)
Books 2

1. Tıp Dalları Tarihçesi

YAKINCI M. C., TANRIVERDİ L. H., ERKURT M. A., ALTUNTAŞ F., YİĞENOĞLU T. N.
Nobel Tıp Kitabevleri, İstanbul, 2023

2. KLİNİK HEMATOLOJİ ONKOLOJİ ATLASI

AYDOGDU İ., KAYA E., KUKU İ., ATEŞ F., ULU R., BAYDAR M., et al.
Sistem Sistem Ofset Basım Yayım, Ankara, 2004
Metrics

Publication

274

Publication (WoS)

99

Publication (Scopus)

96

Citation (WoS)

370

H-Index (WoS)

10

Citation (Scopus)

656

H-Index (Scopus)

14

Citation (TrDizin)

6

H-Index (TrDizin)

2

Citation (Sum Other)

32

Project

1

Thesis Advisory

15

Open Access

23
UN Sustainable Development Goals
SDG 1: GOAL 1: NO POVERTY
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 9: GOAL 9: INDUSTRIAL INNOVATION AND INFRASTRUCTURE
SDG 15: GOAL 15: LIFE ON LAND
SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS